Drug Discovery and Development

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Jaguar Gene Therapy Announces Plans for New Commercial Manufacturing Facility in NC

The 174,000-square-foot facility will support future clinical and commercial production of the company’s initial programs.

10.27.21

Waters and Sartorius Enter Bioprocessing Partnership

Collaboration to help bioprocess scientists accelerate clone selection and process development.

10.27.21

Chemistry | Extractables and Leachables | Microbiology

SGS Health Science

...

Jessica Martin, Marketing Director 10.26.21

Collaborations & Alliances | Drug Development

Secarna, Denali Therapeutics Expand Strategic CNS Pact

To broaden use of Secarna's ASO discovery and development platform LNAplus and Denali's blood-brain barrier Transport Vehicle technology.

10.26.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

BioNTech to Build mRNA Vaccine Mfg. Facility in Africa

The first mRNA manufacturing facility in Africa will enable an annual manufacturing capacity of several hundreds of million mRNA vaccine doses.

10.26.21

Collaborations & Alliances | Drug Delivery

Aptar Pharma Enters Exclusive Partnership with Stallergenes Greer

Will develop a novel digital health ecosystem for allergen immunotherapy treatment.

10.26.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Invests $230M in Harmans Gene Therapy Campus

Will house 18 CGMP viral vector manufacturing suites designed to accommodate multiple bioreactors up to 2,000-liter scale and commercial manufacturing.

10.26.21

Bio News | Biologics, Proteins, Vaccines | Facilities | Industry News

GTP Bioways Invests $14M in Biopharma Production Capabilities in France

Strengthens position as a CDMO in Europe by opening two new biopharmaceutical production units at Toulouse site.

10.25.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Absci Opens Door to New Biotechnology Campus

Vancouver, WA headquarters expands company’s ability to accelerate discovery and development of next generation biologic drugs.

10.25.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Exacis Biotherapeutics Partners with CCRM

Includes a cash investment into Exacis by CCRM Enterprises Holdings Ltd., which will be used to fund operations.

10.25.21

Breaking News | Drug Delivery | Facilities | Industry News

Renaissance Lakewood Marks Major Facility Expansion

Global CDMO invests more than $40 million in infrastructure, equipment and technology for 370,000 sq. ft. state-of-the-art Ocean County, NJ campus.

10.25.21

Breaking News | Collaborations & Alliances | Industry News | Information Technology

HistoWiz Closes $32 Million Series A Financing

The round was led by Vivo Capital and included other investors venBio, Asahi Kasei and Jon Oringer.

10.25.21

I-Mab Opens New R&D Lab in San Diego

Strengthens global R&D presence with a new integrated lab and operational site in the rapidly growing San Diego biotech hub.

10.22.21

Breaking News | Drug Delivery | Formulation Development | Industry News

Aptar Pharma, i2c Pharma Services Partner on Next-Gen pMDI

Aptar has exclusive option for a worldwide license to i2c’s Respitab technology.

10.21.21

Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances

Waters Corp., Delaware University Enter Bioprocessing Research Pact

Aims to develop new analytical solutions to address significant challenges for bioprocessing and biomanufacturing at Immerse Delaware Lab.

10.21.21

Biologics, Proteins, Vaccines | Breaking News | Trials & Filings

Moderna COVID-19 Vax Booster Authorized Under EUA

For people 65 and older; aged 18 to 64 who are at high risk of severe COVID-19 and for eligible individuals who received a different COVID-19 vaccine.

10.21.21

Biologics, Proteins, Vaccines | Breaking News | Trials & Filings